Literature DB >> 10907848

Cbfa1, an essential transcription factor for bone formation, is expressed in testis from the same promoter used in bone.

S Ogawa1, H Harada, M Fujiwara, S Tagashira, T Katsumata, H Takada.   

Abstract

Cbfa1 is an essential transcription factor for bone formation, but its transcripts have also been detected in thymus and testis. To elucidate the expression of Cbfa1 in testis, we isolated Cbfa1 cDNA from mouse testis. First we examined the length of the transcripts expressed in mouse testis by Northern hybridization. Using a cDNA probe that can detect both Type-I and Type-II Cbfa1 (Type-I: originally reported as Pebp2alphaA by Ogawa et al.; Type-II: originally reported as til-1 by Stewart et al.), 1.8-kb transcripts were detected in testis, and larger transcripts (6.3 kb and 7.4 kb) in T-cell lines, thymus and bone. Using a Type-II specific probe (bone isoform-specific probe), surprisingly, 1.8-kb testis transcript(s) were detected as well as those (6.3 kb) found in bone. In addition, the transcription start site in mouse testis coincides with one of three start sites identified in bone. These results suggest that the testis transcript is generated from the same promoter of Type-II Cbfa1, which is thought to be active only in osteoblasts and some chondrocytes. Next, to define the difference in length of transcripts, we isolated the Cbfa1 cDNA from mouse testis. Sequence analysis of the cDNA showed that alternative splicing around exon 2 and poly-adenylation within exon 8 occurred in the testis isoform, which produce the smaller transcripts. These data revealed that testis Cbfa1 mRNA is transcribed from same promoter used in bones, but the post-transcriptional regulation is different between testis and skeletal tissues.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10907848     DOI: 10.1093/dnares/7.3.181

Source DB:  PubMed          Journal:  DNA Res        ISSN: 1340-2838            Impact factor:   4.458


  6 in total

1.  Subnuclear targeting of Runx/Cbfa/AML factors is essential for tissue-specific differentiation during embryonic development.

Authors:  J Y Choi; J Pratap; A Javed; S K Zaidi; L Xing; E Balint; S Dalamangas; B Boyce; A J van Wijnen; J B Lian; J L Stein; S N Jones; G S Stein
Journal:  Proc Natl Acad Sci U S A       Date:  2001-07-03       Impact factor: 11.205

2.  The Runx2 osteogenic transcription factor regulates matrix metalloproteinase 9 in bone metastatic cancer cells and controls cell invasion.

Authors:  Jitesh Pratap; Amjad Javed; Lucia R Languino; Andre J van Wijnen; Janet L Stein; Gary S Stein; Jane B Lian
Journal:  Mol Cell Biol       Date:  2005-10       Impact factor: 4.272

3.  The transcription factor RUNX2 drives the generation of human NK cells and promotes tissue residency.

Authors:  Sigrid Wahlen; Filip Matthijssens; Wouter Van Loocke; Sylvie Taveirne; Laura Kiekens; Eva Persyn; Els Van Ammel; Zenzi De Vos; Stijn De Munter; Patrick Matthys; Filip Van Nieuwerburgh; Tom Taghon; Bart Vandekerckhove; Pieter Van Vlierberghe; Georges Leclercq
Journal:  Elife       Date:  2022-07-06       Impact factor: 8.713

4.  Initial Characterization of Osteoblast Differentiation and Loss of RUNX2 Stability in the Newly Established SK11 Human Embryonic Stem Cell-Derived Cell Line.

Authors:  Jia-Li Yu; Helty Adisetiyo; Gillian H Little; C Thomas Vangsness; Jianjie Jiang; Hal Sternberg; Michael D West; Baruch Frenkel
Journal:  J Cell Physiol       Date:  2015-02       Impact factor: 6.384

5.  Expression of Runx2 transcription factor in non-skeletal tissues, sperm and brain.

Authors:  Jae-Hwan Jeong; Jung-Sook Jin; Hyun-Nam Kim; Sang-Min Kang; Julie C Liu; Christopher J Lengner; Florian Otto; Stefan Mundlos; Janet L Stein; Andre J van Wijnen; Jane B Lian; Gary S Stein; Je-Yong Choi
Journal:  J Cell Physiol       Date:  2008-11       Impact factor: 6.384

6.  A variant of Runx2 that differs from the bone isoform in its splicing is expressed in spermatogenic cells.

Authors:  Satoru Kanto; Marcin Grynberg; Yoshiyuki Kaneko; Jun Fujita; Masanobu Satake
Journal:  PeerJ       Date:  2016-04-04       Impact factor: 2.984

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.